Anti-tumoral, antibacterial and antiviral pharmaceutical composition (variants)
一种抗肿瘤、抗病毒的技术,应用在生产医学和兽医用途药品的制药,具有综合抗肿瘤,药物组合物,抗菌和抗病毒活性的物质领域,能够解决有病机体免疫系统保护功能下降、抗肿瘤活性不够高、毒副作用等问题
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] Mix 0.016 g of silver nitrate with 0.03 g of hexamethylenetetramine and 0.02 g of sodium thiosulfate, add 0.07 g of α-aspartic acid and 0.07 g of niacin, and dissolve them all in the required amount of in the water. The solution showed some turbidity and the resulting composition was studied for antitumor, antibacterial and antiviral activity.
Embodiment 2
[0037] Mix 1 g of silver nitrate, 0.8 g of hexamethylenetetramine and 3 g of sodium thiosulfate, add 0.4 g of niacin and 0.4 g of alpha-aspartic acid or asparagine, both dissolved in the required amount of water, to obtain solutions to study its antitumor, antibacterial and antiviral activities.
Embodiment 3
[0039] 1.6 g of silver nitrate was mixed with 1.4 g of hexamethylenetetramine and 5 g of sodium thiosulfate, and 0.7 g of α-asparagine and 0.7 g of niacin were added, all dissolved in the required amount of water. Part of the reagents became precipitated, and the resulting composition was studied for antitumor, antibacterial, and antiviral activities.
[0040] embedded trace 3 H-thymidine has carried out the antitumor activity of inhibiting cell growth to tumor cells according to the second scheme of the pharmaceutical composition of the present invention (comprising the platinum compound component containing imidazole) through 24 hours of latent (pulse per minute) For comparison, radioactivity measurements were performed on a β-counter Mark-III. The evaluation of the cell growth inhibitory activity of the pharmaceutical composition of the present invention is in the presence of 10% calf embryo serum (2 * 10 5 cells / ml) of human (K-562 and HUT-102 lines) erythrocytic tissue ...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 